These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1593370)

  • 1. Pharmacokinetics and safety of a new solution of vitamin K1(20) in children with cholestasis.
    Amédée-Manesme O; Lambert WE; Alagille D; De Leenheer AP
    J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):160-5. PubMed ID: 1593370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerance of intravenous and intramuscular phylloquinone (vitamin K1) mixed micelles formulation.
    Soedirman JR; De Bruijn EA; Maes RA; Hanck A; Grüter J
    Br J Clin Pharmacol; 1996 Jun; 41(6):517-23. PubMed ID: 8799516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous allergic reaction to intramuscular vitamin K1.
    Wong DA; Freeman S
    Australas J Dermatol; 1999 Aug; 40(3):147-52. PubMed ID: 10439527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal absorption of mixed micellar phylloquinone (vitamin K1) is unreliable in infants with conjugated hyperbilirubinaemia: implications for oral prophylaxis of vitamin K deficiency bleeding.
    Pereira SP; Shearer MJ; Williams R; Mieli-Vergani G
    Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F113-8. PubMed ID: 12598499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral vitamin K1 prophylaxis for newborns with a new mixed-micellar preparation of phylloquinone: 3 years experience in Switzerland.
    Schubiger G; Stocker C; Bänziger O; Laubscher B; Zimmermann H
    Eur J Pediatr; 1999 Jul; 158(7):599-602. PubMed ID: 10412823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma vitamin K1 and PIVKA-II after oral administration of mixed-micellar or cremophor EL-solubilized preparations of vitamin K1 to normal breast-fed newborns.
    Schubiger G; Grüter J; Shearer MJ
    J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):280-4. PubMed ID: 9138173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.
    Marinova M; Lütjohann D; Breuer O; Kölsch H; Westhofen P; Watzka M; Mengel M; Stoffel-Wagner B; Hartmann G; Coch C; Oldenburg J
    Eur J Clin Pharmacol; 2013 Mar; 69(3):467-75. PubMed ID: 22864379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K1 concentration in breast-fed neonates after oral or intramuscular administration of a single dose of a new mixed-micellar preparation of phylloquinone.
    Schubiger G; Tönz O; Grüter J; Shearer MJ
    J Pediatr Gastroenterol Nutr; 1993 May; 16(4):435-9. PubMed ID: 8315554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of oral administration of a micellaar solution of vitamin K during the neonatal period].
    Maurage C; Dalloul C; Moussa F; Cara B; Dudragne D; Lion N; Amédée-Manesme O
    Arch Pediatr; 1995 Apr; 2(4):328-32. PubMed ID: 7780540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics and lipoprotein fraction distribution of intramuscular vs. oral vitamin K1 supplementation in women of childbearing age: effects on hemostasis.
    Hagstrom JN; Bovill EG; Soll RF; Davidson KW; Sadowski JA
    Thromb Haemost; 1995 Dec; 74(6):1486-90. PubMed ID: 8772225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease.
    Pereira SP; Rowbotham D; Fitt S; Shearer MJ; Wendon J; Williams R
    J Hepatol; 2005 Mar; 42(3):365-70. PubMed ID: 15710219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The bioavailability of a mixed micellar preparation of vitamin K1, and its procoagulant effect in anticoagulated rabbits.
    Winn MJ; White PM; Scott AK; Pratt SK; Park BK
    J Pharm Pharmacol; 1989 Apr; 41(4):257-60. PubMed ID: 2568466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vitamin K 1 concentration and vitamin K-dependent clotting factors in newborn infants after intramuscular and oral administration of vitamin K 1].
    Goldschmidt B; Kisrákói C; Téglás E; Verbényi M; Kovács I
    Orv Hetil; 1990 Jun; 131(24):1297-300. PubMed ID: 2195426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the Severe Reactions of Parenteral Vitamin K1.
    Britt RB; Brown JN
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):5-12. PubMed ID: 28301903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal plasma vitamin K1 levels following oral and intramuscular administration of vitamin K1.
    Gupta JM; Salonikas C; Naidoo D
    Acta Paediatr; 1994 Feb; 83(2):133-4. PubMed ID: 8193487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does intramuscular vitamin K1 act as an unintended depot preparation?
    Loughnan PM; McDougall PN
    J Paediatr Child Health; 1996 Jun; 32(3):251-4. PubMed ID: 8827545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral versus intramuscular phytomenadione: safety and efficacy compared.
    von Kries R
    Drug Saf; 1999 Jul; 21(1):1-6. PubMed ID: 10433349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mixed Micelle Formulation for Oral Delivery of Vitamin K.
    Sun F; Jaspers TC; van Hasselt PM; Hennink WE; van Nostrum CF
    Pharm Res; 2016 Sep; 33(9):2168-79. PubMed ID: 27245464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in hepatic vitamin K1 levels after prophylactic administration to the newborn.
    Guillaumont M; Sann L; Leclercq M; Dostalova L; Vignal B; Frederich A
    J Pediatr Gastroenterol Nutr; 1993 Jan; 16(1):10-4. PubMed ID: 8433228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late onset haemorrhagic disease in premature infants who received intravenous vitamin K1.
    Loughnan PM; McDougall PN; Balvin H; Doyle LW; Smith AL
    J Paediatr Child Health; 1996 Jun; 32(3):268-9. PubMed ID: 8827551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.